AbbVie Stock Outlook: Is Wall Street Bullish or Bearish?

North Chicago, Illinois-based AbbVie Inc. (ABBV) is a research-based biopharmaceutical company. Valued at a market cap of $348.3 billion, it researches, develops, manufactures, and markets innovative medicines and therapies across a range of therapeutic areas.

This healthcare giant has lagged behind the broader market over the past 52 weeks. Shares of AbbVie have gained 4.2% over this time frame, while the broader S&P 500 Index ($SPX) has surged 18.4%. Nonetheless, on a YTD basis, the stock is up 11%, outpacing SPX’s 7.6% return.